Skip to main content
    G

    Gilead Sciences Inc (GILD)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $167.58
    -0.50 (-0.30%)

    Market Cap: $208.48B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Gilead Sciences Inc (GILD) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Gilead Sciences are GSK (GSK), Amgen (AMGN) and Bristol-Myers Squibb Company (BMY). By market cap, Gilead Sciences ranks 7th of the 13 companies on this page; Eli Lilly and Company (LLY) is the largest at $1.29T. The median P/E of the 10 companies with a P/E is 20.7x.

    Peer Comparison

    GILD's ROIC of -3.9% is below the peer median of 13.9%, and its revenue growth of 6.8% is in line with the median. Its dividend yield is below the peer median of 2.67%.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Gilead Sciences (GILD)$208.48BN/A6.7x-12.5%-3.9%6.8%1.96%
    GSK plc (GSK)$101.13B10.5x2.3x13.0%N/A4.0%3.58%
    Amgen Inc (AMGN)$251.89B19.9x6.4x24.1%17.0%8.5%2.18%
    Bristol-Myers Squibb Company (BMY)$129.66B10.1x2.6x18.5%13.9%6.9%4.00%
    Novo Nordisk A/S (NVO)$183.52BN/A3.6x33.9%34.1%5.6%4.32%
    Pfizer Inc (PFE)$164.67B9.5x2.6x6.3%2.7%-0.4%5.96%
    Sanofi ADR (SNY)$116.15BN/A2.0x8.2%7.6%15.7%5.01%
    AstraZeneca PLC (AZN)$286.07B22.5x4.6x17.7%14.9%6.7%1.16%
    AbbVie Inc (ABBV)$521.50B23.0x7.9x15.7%16.4%10.3%2.35%
    Novartis AG ADR (NVS)$303.12B18.7x5.4x17.5%13.5%4.7%2.98%
    Merck & Company Inc (MRK)$364.26B46.3x5.3x3.6%3.1%4.7%2.35%
    Biogen Inc (BIIB)$37.46B21.4x3.6x3.4%1.3%10.6%0.00%
    Eli Lilly and Company (LLY)$1.29T44.9x14.8x31.9%30.7%38.6%0.48%
    Peer median$217.70B20.7x4.1x16.6%13.9%6.8%2.67%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Gilead Sciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - General.

    CompanyAboutPeers
    GSK plc (GSK)
    GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines...
    GSK competitors
    Amgen Inc (AMGN)
    Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
    AMGN competitors
    Bristol-Myers Squibb Company (BMY)
    Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City.
    BMY competitors
    Novo Nordisk A/S (NVO)
    Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally.
    NVO competitors
    Pfizer Inc (PFE)
    Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City.
    PFE competitors
    Sanofi ADR (SNY)
    Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe...
    SNY competitors
    AstraZeneca PLC (AZN)
    AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory...
    AZN competitors
    AbbVie Inc (ABBV)
    AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
    ABBV competitors
    Novartis AG ADR (NVS)
    Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
    NVS competitors
    Merck & Company Inc (MRK)
    Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey.
    MRK competitors
    Biogen Inc (BIIB)
    Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development...
    BIIB competitors
    Eli Lilly and Company (LLY)
    Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries.
    LLY competitors

    Frequently Asked Questions About GILD

    Who are Gilead Sciences' main competitors?

    The companies most similar to Gilead Sciences include GSK (GSK), Amgen (AMGN), Bristol-Myers Squibb Company (BMY), Novo Nordisk A/S (NVO) and Pfizer (PFE), listed from the closest match.

    Who is Gilead Sciences' biggest competitor?

    Eli Lilly and Company (LLY) is the largest of the similar companies at $1.29T; GSK (GSK) is the closest match by business profile, size, sector and industry.

    How does GILD stock compare with its competitors?

    GILD's P/S is 6.7x against a peer median of 4.1x; its net margin is -12.5% against a peer median of 16.6%.

    Which of Gilead Sciences' competitors pays a higher dividend?

    Gilead Sciences has a forward dividend yield of 1.96%. Pfizer (PFE), Sanofi ADR (SNY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb Company (BMY), GSK (GSK), Novartis AG ADR (NVS), Merck & Company (MRK), AbbVie (ABBV) and Amgen (AMGN) have higher forward dividend yields; Pfizer (PFE) has the highest at 5.96%.

    Is Gilead Sciences bigger than its competitors?

    No. Gilead Sciences is 7th by market cap among the 13 companies on this page; the largest is Eli Lilly and Company (LLY) at $1.29T.